TAMAR D. HOWSON - 01 Jul 2021 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Issuer symbol
MEIP
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4
Filing time
06 Jul 2021, 19:00:43 UTC
Previous filing
14 Jun 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 01 Jul 2021 Common Stock 50,000 $2.95 Direct F1
holding MEIP Stock Option (Right to Buy) 60,000 01 Jul 2021 Common Stock 60,000 $2.52 Direct F2
holding MEIP Stock Option (Right to Buy) 50,000 01 Jul 2021 Common Stock 50,000 $3.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in equal monthly installments over twelve months.
F2 40,000 of the options vested on July 1, 2020, and are currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019.
F3 All of such options are presently exercisable.